COX-2 inhibitors were demonstrated to alleviate memory impairment in diabetic rat model (Yang and Gao 2017), Alzheimer’s disease rat model (Mhillaj et al. 2018), and in humans with first manifestation of schizophrenia (Müller et al. 2010). Here, PTGS2 is linked to memory impairment.